Articles with public access mandates - Jeffrey CurtisLearn more
Not available anywhere: 43
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis
KG Saag, GG Teng, NM Patkar, J Anuntiyo, C Finney, JR Curtis, ...
Arthritis Care & Research: Official Journal of the American College of …, 2008
Mandates: US National Institutes of Health
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
K Au, G Reed, JR Curtis, JM Kremer, JD Greenberg, V Strand, DE Furst
Annals of the rheumatic diseases 70 (5), 785-791, 2011
Mandates: US National Institutes of Health
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs
DH Solomon, JM Kremer, M Fisher, JR Curtis, V Furer, LR Harrold, ...
Seminars in arthritis and rheumatism 43 (4), 489-497, 2014
Mandates: US National Institutes of Health
Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms
LW Moreland, JR Curtis
Seminars in arthritis and rheumatism 39 (2), 132-143, 2009
Mandates: US National Institutes of Health
Characteristics and health-care utilization history of patients with bronchiectasis in US Medicare enrollees with prescription drug plans, 2006 to 2014
E Henkle, B Chan, JR Curtis, TR Aksamit, CL Daley, KL Winthrop
Chest 154 (6), 1311-1320, 2018
Mandates: Patient-Centered Outcomes Research Institute
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program
J Zhang, F Xie, E Delzell, L Chen, ML Kilgore, H Yun, KG Saag, JD Lewis, ...
Arthritis care & research 65 (11), 1743-1751, 2013
Mandates: US National Institutes of Health
Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan
SW Wade, JR Curtis, J Yu, J White, BS Stolshek, C Merinar, ...
Bone 50 (4), 870-875, 2012
Mandates: US National Institutes of Health
Patient perspectives on achieving treat‐to‐target goals: a critical examination of patient‐reported outcomes
JR Curtis, Y Shan, L Harrold, J Zhang, JD Greenberg, GW Reed
Arthritis care & research 65 (10), 1707-1712, 2013
Mandates: US National Institutes of Health
Predictors of achieving remission among patients with psoriatic arthritis initiating a tumor necrosis factor inhibitor
A Ogdie, JL Palmer, J Greenberg, JR Curtis, LR Harrold, DH Solomon, ...
The Journal of rheumatology 46 (5), 475-482, 2019
Mandates: US National Institutes of Health
Association of infections and tuberculosis with antitumor necrosis factor alpha therapy
NM Patkar, GG Teng, JR Curtis, KG Saag
Current opinion in rheumatology 20 (3), 320-326, 2008
Mandates: US National Institutes of Health
Digital interventions to build a patient registry for rheumatology research
WB Nowell, D Curtis, M Thai, C Wiedmeyer, K Gavigan, S Venkatachalam, ...
Rheumatic Disease Clinics 45 (2), 173-186, 2019
Mandates: Patient-Centered Outcomes Research Institute
Serious infections in rheumatoid arthritis offspring exposed to tumor necrosis factor inhibitors: a cohort study
É Vinet, C De Moura, CA Pineau, M Abrahamowicz, JR Curtis, ...
Arthritis & Rheumatology 70 (10), 1565-1571, 2018
Mandates: Fonds de recherche du Québec - Santé, Patient-Centered Outcomes Research …
Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy
HN Viswanathan, JR Curtis, J Yu, J White, BS Stolshek, C Merinar, ...
Applied health economics and health policy 10, 163-173, 2012
Mandates: US National Institutes of Health
An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database
S Unni, Y Yao, N Milne, K Gunning, JR Curtis, J LaFleur
Osteoporosis International 26, 581-587, 2015
Mandates: US National Institutes of Health
A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab
M Ray, JR Curtis, JW Baddley
Annals of the rheumatic diseases 73 (7), 1429-1430, 2014
Mandates: US National Institutes of Health
Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study
JR Curtis, F Xie, L Chen, KG Saag, H Yun, P Muntner
Annals of the rheumatic diseases 77 (3), 386-392, 2018
Mandates: Patient-Centered Outcomes Research Institute
Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors
ML Mannion, F Xie, JR Curtis, T Beukelman
The Journal of rheumatology 41 (10), 2078-2084, 2014
Mandates: US National Institutes of Health
Studies with herpes zoster vaccines in immune compromised patients
MJ Levin, E Bresnitz, Z Popmihajlov, A Weinberg, KL Liaw, E Willis, ...
Expert review of vaccines 16 (12), 1217-1230, 2017
Mandates: US National Institutes of Health
Benefits of methotrexate use on cardiovascular disease risk among rheumatoid arthritis patients initiating biologic disease-modifying antirheumatic drugs
F Xie, L Chen, H Yun, EB Levitan, JR Curtis
The Journal of Rheumatology 48 (6), 804-812, 2021
Mandates: Patient-Centered Outcomes Research Institute
Use of scribes for documentation assistance in rheumatology and endocrinology clinics: impact on clinic workflow and patient and physician satisfaction
MI Danila, JA Melnick, JR Curtis, N Menachemi, KG Saag
JCR: Journal of Clinical Rheumatology 24 (3), 116-121, 2018
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program